All posts

The IPO Machine Shifts Into Higher Gear: Can the Market Absorb What's Coming?

SK hynix's record $26.5B Nasdaq debut caps a first half that put $155.8B of new paper into US markets. Ahead lie Csquare and Standard Nuclear this week, SpaceX lockup unlocks starting late July, and an Anthropic/OpenAI pipeline that could add tens of billions more.

A modern skyscraper with a reflective glass facade capturing the urban architectural style.
Photo by wal_ 172619 on PexelsPhoto by Stas Knop on PexelsPhoto by K on Pexels

The US IPO market enters mid-July 2026 having already printed more paper than any full year since 2021. Nineteen-four IPOs have raised $155.8 billion year-to-date as of July 2, with SpaceX alone accounting for $86.2 billion — more than half the total{{cite:7e60e0dd66b2}}. Even excluding SpaceX, the remaining $69.9 billion of US IPO proceeds more than doubles the $31.6 billion raised in the same period of 2025{{cite:7e60e0dd66b2}}. The question for the second half is no longer whether the pipeline is open — it is how much supply the market can digest before something bends.

The most recent test came on July 10, when SK hynix priced its American Depositary Receipts at $149 and raised $26.5 billion in the largest foreign IPO on a US exchange in history{{cite:10fece256078}}. The ADRs opened at $170, a 14% premium, and closed the first session at $168.01, up 13%{{cite:10fece256078}}. Chairman Chey Tae-won struck an unmistakable demand-tone in his debut-day comments: “demand is enormous”{{cite:10fece256078}}. The deal was 7x oversubscribed, according to one report{{cite:10fece256078}}. SK hynix occupies a singular position in the AI supply chain as the dominant producer of HBM3E memory used in NVIDIA’s most advanced accelerators, and the offering gave US investors their first direct line into that exposure without round-tripping through Korea’s exchange.

Close-up view of a graphics processing unit held in hand against a gray background

This Week’s Calendar: Data Centers and Nuclear Fuel

Two sized deals are scheduled for the week ahead, though smaller transactions may join throughout the week{{cite:fdc796956a8a}}.

Issuer Ticker Deal Size Market Cap Price Range Sector Key Risk
Csquare CSQR $1.25B $3.9B $23–$27 Data center colocation 12.1x net debt/LTM adjusted EBITDA
Standard Nuclear STDN $356M $3.7B $18–$21 SMR nuclear fuel No commercial HALEU supply in the US

Csquare operates 64 carrier-neutral colocation facilities across 21 US metropolitan markets, with adjusted EBITDA margins that have expanded from 9% in 2023 to 40% on an LTM basis{{cite:fdc796956a8a}}. The leverage profile — 12.1x net debt to LTM adjusted EBITDA — is the trade-off investors must underwrite{{cite:fdc796956a8a}}. Standard Nuclear designs and manufactures TRISO fuel for small modular reactors and microreactors, operating the only dedicated, privately funded industrial-scale TRISO production line in the United States after acquiring assets from Ultra Safe Nuclear through a 2024 bankruptcy auction{{cite:fdc796956a8a}}. Its $245 million contract backlog is real, but its manufacturing depends on enriched uranium feedstock (HALEU) that currently has no domestic commercial supply{{cite:fdc796956a8a}}.

Nuclear power plant cooling towers silhouetted against a sunset sky

Both deals fit the pattern Morgan Stanley identified in May: the 2026 IPO pipeline is skewing larger and later-stage, driven by AI infrastructure and aerospace/defense secular themes, with financial sponsors pushing mature portfolio companies toward public exits{{cite:2957838153aa}}. Eddie Molloy, Morgan Stanley’s Global Co-Head of Equity Capital Markets, framed it plainly: “It’s not just data centers coming to market. It’s the entire ecosystem — service providers, power infrastructure, industrial components — everything required to support that growth”{{cite:2957838153aa}}.

The SpaceX Lockup Clock

SpaceX’s June 12 debut — 115 million shares at $135, valuing the company at nearly $1.77 trillion, with total proceeds reaching $85.7 billion after the greenshoe — is the gravitational center of this market{{cite:b53e1adb3b27}}. Shares surged past $225 in the sessions that followed, then reversed to roughly $153 by late June, a ~32% decline from the post-listing peak{{cite:b53e1adb3b27}}. The stock trades under SPCX on Nasdaq and has already been added to the Nasdaq-100.

What makes SpaceX structurally different is its lockup architecture. Instead of the standard 180-day cliff, the S-1 built in a series of phased release valves{{cite:3d8110a98469}}:

  • After Q2 earnings (late July/early August): Insiders can sell up to 20% of their eligible locked-up shares. If the stock is trading at least 30% above the $135 IPO price at that point, an additional 10% unlocks.
  • Rolling schedule at 70, 90, 105, 120, and 135 days post-IPO: Another 7% unlocks at each interval.
  • After Q3 earnings (three months through September): An additional 28% becomes sellable.
  • At 180 days: Whatever remains is fully released.

Elon Musk, who holds roughly 42% of the equity and 82% of voting power through Class B shares, is excluded from all early-release provisions{{cite:3d8110a98469}}. Only about 4% of SpaceX shares currently trade freely; that figure could approach 40% by December as the phased unlocks proceed{{cite:4c3ca389a442}}.

The first earnings report as a public company, expected in late July or early August, is therefore the next critical date. A banker quoted by ION Analytics put it directly: “If SpaceX starts to trade down that could close the door for other AI issuers”{{cite:7e60e0dd66b2}}. That is the sentinel risk for the second-half pipeline.

The $200B Pipeline and the Inelastic Markets Problem

Behind the deals already priced sits a pipeline that JPMorgan projects will push total 2026 equity issuance above $260 billion — a threshold not crossed since 2021{{cite:b53e1adb3b27}}. Anthropic confidentially filed its S-1 on June 1 after a $65 billion funding round at a $965 billion private valuation{{cite:b53e1adb3b27}}. OpenAI filed on June 8, though a listing may slip to 2027 as CEO Sam Altman holds firm on a $1 trillion valuation target, above the company’s $852 billion private mark{{cite:b53e1adb3b27}}. Former Nasdaq chief Robert Greifeld has said he expects both to go public before the end of 2026{{cite:b53e1adb3b27}}.

The structural concern is how prices respond when capital rotates from existing holdings into new listings. The “inelastic markets hypothesis” developed by Xavier Gabaix and Ralph Koijen (NBER) finds that every $1 flowing into or out of equities shifts total market value by approximately $5, because index funds, pension funds, and insurers hold the bulk of equities under mandates that limit their ability to absorb sudden demand shifts{{cite:b53e1adb3b27}}. Applied to a $200 billion IPO wave, that implies roughly $1 trillion in aggregate market value at risk{{cite:b53e1adb3b27}}.

I would put the probability that this supply wave produces a sustained market-level drawdown exceeding 5% at roughly 35%. The reasoning: the mechanism is real and directionally sound, but three offsets narrow the risk.

Offset 1: Corporate buybacks. JPMorgan Private Bank strategist Abigail Yoder’s June note projects corporate share repurchases at approximately $1.5 trillion in 2026, against $260 billion in projected new equity issuance — a 5.8:1 demand-to-supply ratio{{cite:b53e1adb3b27}}. “Even in a scenario where IPO volumes rise more than expected, and lockup expiries add incremental pressure, corporate demand alone may have the capacity to absorb a large share of equity supply coming to market,” the strategists wrote{{cite:b53e1adb3b27}}. Active buyback programs visible this month include ING’s €1.0 billion repurchase (950,000 shares at an average €27.65 in the week of June 29–July 3){{cite:bc5ec8d29c19}} and Banco Santander’s ongoing program{{cite:bc5ec8d29c19}}. SRX Global’s board authorized a repurchase of up to 10 million shares, or 50% of shares outstanding{{cite:bc5ec8d29c19}}.

Offset 2: Market scale. The S&P 500’s total market capitalization has grown to over $65 trillion, about 55% larger than in 2021, the last comparable issuance cycle{{cite:b53e1adb3b27}}. The same nominal supply represents a smaller fraction of the market’s absorptive capacity.

Offset 3: Historical base rates. JPMorgan found that two-thirds of the 25 largest IPOs in history were followed by positive S&P 500 returns over the subsequent 12 months, with gains ranging from 5% to 20%{{cite:b53e1adb3b27}}. Large listings tend to accompany uptrends rather than terminate them.

The 65% probability on the other side — that the market absorbs the supply without a sustained drawdown — is not a clean bill of health. It is a statement that the offsets are large but imperfect, and the concentration risk is the crack in the foundation.

The Concentration Problem

Full index inclusion of SpaceX, Anthropic, and OpenAI would push the S&P 500’s effective technology weighting to 54% from its current 51%, counting Alphabet, Meta, and Amazon alongside traditional technology names{{cite:b53e1adb3b27}}. For context, the technology sector’s weight peaked at approximately 35% in early 2000, just before the dot-com crash{{cite:b53e1adb3b27}}. Neuberger Berman’s CIO team flagged the shift as a meaningful increase in portfolio concentration risk for passive index holders{{cite:b53e1adb3b27}}.

Goldman Sachs projects S&P 500 EPS of $340 in 2026, a 24% year-over-year increase, with AI infrastructure beneficiaries contributing roughly half of that earnings growth{{cite:b53e1adb3b27}}. The market’s gains are becoming as concentrated as its supply.

The European Counterweight

While US ECM soars, European listings continue to flounder. The Franco-German tank maker KNDS postponed its IPO at the start of the second half after poor trading among defense peers and a wide valuation gap — family shareholders wanted at least €12.5 billion; investors demanded a substantial discount{{cite:7e60e0dd66b2}}. Dealogic’s IPO Health Index for the Americas is near post-2021 highs, while the EMEA index sits near its post-2021 nadir{{cite:7e60e0dd66b2}}.

The structural diagnosis from ION Analytics: Europe relies on a smaller, more selective investor base of mutual funds and hedge funds, lacks the retail participation that propelled SpaceX, and investors routinely demand at least a 30% discount to peers to participate in new listings{{cite:7e60e0dd66b2}}. A banker close to the KNDS deal put it bluntly: “Recent reforms to facilitate listings in Europe are great to speed up listing preparations but we now need to encourage pension funds and more retail investors”{{cite:7e60e0dd66b2}}.

Market-Structure Watch: Tokenized Listings and Secondary Supply

Securitize Corp. (NYSE: SECZ) became the first company to simultaneously list common stock on a traditional exchange and issue tokenized versions on blockchain networks, making $295 million of its own stock available on Solana and Avalanche on its July 2 listing day{{cite:a2d886282a6e}}. The BlackRock-backed firm completed its de-SPAC combination with Cantor Equity Partners II and trades under SECZ{{cite:a2d886282a6e}}. The dual-market debut was enabled by regulatory changes formalized only six months earlier{{cite:a2d886282a6e}}. Whether tokenized equities meaningfully expand the investor base for future IPOs or remain a niche instrument is a 2027 question, but the precedent is set.

On the secondary side, Sable Offshore Corp. (NYSE: SOC) priced 32.5 million shares at $3.08 alongside $300 million in 6.5% convertible senior notes due 2031 in a concurrent offering{{cite:bd6d6d3ea411}}. Rackspace Technology filed an at-the-market equity distribution agreement with Goldman Sachs for up to $250 million in common stock{{cite:bd6d6d3ea411}}. IperionX (NASDAQ: IPX) priced a 2.275 million share follow-on at $21.98{{cite:bd6d6d3ea411}}. None of these are headline-grabbing, but they represent the steady drip of secondary supply that compounds alongside the IPO wave.

What to Watch Next

  1. SpaceX Q2 earnings (late July/early August): The first trigger for lockup releases. If the stock is above $175.50 (30% over the $135 IPO price), insiders gain an additional 10% of sellable shares on top of the base 20%. The stock’s reaction sets the tone for the entire AI-issuer pipeline.

  2. Csquare (CSQR) and Standard Nuclear (STDN) pricing: Both are scheduled for the current week. Csquare’s reception will indicate whether data-center exposure remains as voraciously bid as it was in the first half. Standard Nuclear’s deal tests whether nuclear-fuel supply-chain stories can command a $3.7 billion market cap with no commercial HALEU feedstock.

  3. Anthropic IPO filing visibility: The confidential S-1 was filed June 1. If a public filing emerges in the next 4–8 weeks, it signals a September/October listing window — the scenario one US investor flagged as “terrible for the broader market” if both Anthropic and OpenAI list in close succession{{cite:7e60e0dd66b2}}.

  4. Nasdaq-100 rebalance weighting for SpaceX: As phased lockups increase the free float from ~4% toward 40%, SpaceX’s index weighting mechanically increases, triggering forced index-fund buying. The pace of that float expansion — and whether it outpaces or lags insider selling — determines whether the lockup schedule is a net tailwind or headwind.

  5. Corporate buyback execution pace: The $1.5T annual projection from JPMorgan is the primary supply-absorption mechanism. Q2 2026 earnings season (beginning in earnest next week) will reveal whether buyback authorizations are accelerating or decelerating as companies assess their own valuation levels alongside the issuance glut.